annual SGA:
$1.17B-$375.00M(-24.21%)Summary
- As of today (May 21, 2025), MRNA annual SGA is $1.17 billion, with the most recent change of -$375.00 million (-24.21%) on December 31, 2024.
- During the last 3 years, MRNA annual SGA has risen by +$607.00 million (+107.05%).
- MRNA annual SGA is now -24.21% below its all-time high of $1.55 billion, reached on December 31, 2023.
Performance
MRNA SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly SGA:
$212.00M-$139.00M(-39.60%)Summary
- As of today (May 21, 2025), MRNA quarterly SGA is $212.00 million, with the most recent change of -$139.00 million (-39.60%) on March 31, 2025.
- Over the past year, MRNA quarterly SGA has dropped by -$62.00 million (-22.63%).
- MRNA quarterly SGA is now -54.89% below its all-time high of $470.00 million, reached on December 31, 2023.
Performance
MRNA quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM SGA:
$41.44B-$3.36B(-7.49%)Summary
- As of today (May 21, 2025), MRNA TTM SGA is $41.44 billion, with the most recent change of -$3.36 billion (-7.49%) on March 31, 2025.
- Over the past year, MRNA TTM SGA has increased by +$39.92 billion (+2629.64%).
- MRNA TTM SGA is now -41.30% below its all-time high of $70.59 billion.
Performance
MRNA TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Selling, general & administrative expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
MRNA Selling, general & administrative expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.2% | -22.6% | +2629.6% |
| 3 y3 years | +107.0% | -20.9% | +5366.5% |
| 5 y5 years | +967.3% | +783.3% | +10000.0% |
MRNA Selling, general & administrative expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.2% | +107.0% | -54.9% | +0.5% | -41.3% | +36.2% |
| 5 y | 5-year | -24.2% | +967.3% | -54.9% | +783.3% | -41.3% | +647.1% |
| alltime | all time | -24.2% | >+9999.0% | -54.9% | >+9999.0% | -41.3% | +647.1% |
MRNA Selling, general & administrative expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $212.00M(-39.6%) | $1.11B(-5.3%) |
| Dec 2024 | $1.17B(-24.2%) | $351.00M(+24.9%) | $1.17B(-9.2%) |
| Sep 2024 | - | $281.00M(+4.9%) | $1.29B(-11.1%) |
| Jun 2024 | - | $268.00M(-2.2%) | $1.45B(-4.2%) |
| Mar 2024 | - | $274.00M(-41.7%) | $1.52B(-2.0%) |
| Dec 2023 | $1.55B(+36.8%) | $470.00M(+6.3%) | $1.55B(+6.5%) |
| Sep 2023 | - | $442.00M(+33.1%) | $1.45B(+12.7%) |
| Jun 2023 | - | $332.00M(+8.9%) | $1.29B(+10.4%) |
| Mar 2023 | - | $305.00M(-18.7%) | $1.17B(+3.3%) |
| Dec 2022 | $1.13B(+99.6%) | $375.00M(+34.9%) | $1.13B(+18.2%) |
| Sep 2022 | - | $278.00M(+31.8%) | $958.00M(+13.0%) |
| Jun 2022 | - | $211.00M(-21.3%) | $848.00M(+11.9%) |
| Mar 2022 | - | $268.00M(+33.3%) | $758.00M(+33.7%) |
| Dec 2021 | $567.00M(+201.6%) | $201.00M(+19.6%) | $567.00M(+27.4%) |
| Sep 2021 | - | $168.00M(+38.8%) | $445.00M(+36.9%) |
| Jun 2021 | - | $121.00M(+57.1%) | $325.00M(+34.9%) |
| Mar 2021 | - | $77.00M(-2.5%) | $241.00M(+28.2%) |
| Dec 2020 | $188.00M(+70.9%) | $79.00M(+64.6%) | $188.00M(+39.2%) |
| Sep 2020 | - | $48.00M(+29.7%) | $135.09M(+17.2%) |
| Jun 2020 | - | $37.00M(+54.2%) | $115.26M(+8.0%) |
| Mar 2020 | - | $24.00M(-8.0%) | $106.75M(-3.0%) |
| Dec 2019 | $110.00M(+16.7%) | $26.09M(-7.4%) | $110.00M(-9.8%) |
| Sep 2019 | - | $28.17M(-1.1%) | $121.94M(+8.6%) |
| Jun 2019 | - | $28.49M(+4.5%) | $112.29M(+6.7%) |
| Mar 2019 | - | $27.25M(-28.3%) | $105.19M(+11.6%) |
| Dec 2018 | $94.25M(+45.6%) | $38.02M(+105.3%) | $94.25M(+30.7%) |
| Sep 2018 | - | $18.52M(-13.4%) | $72.13M(+32.9%) |
| Jun 2018 | - | $21.39M(+31.1%) | $54.29M(+63.0%) |
| Mar 2018 | - | $16.32M(+2.6%) | $33.30M(+87.3%) |
| Dec 2017 | $64.72M(+12.7%) | $15.90M(+2238.6%) | $17.78M(+700.4%) |
| Sep 2017 | - | $680.10K(+68.8%) | $2.22M(+39.8%) |
| Jun 2017 | - | $402.80K(-49.4%) | $1.59M(+25.9%) |
| Mar 2017 | - | $795.40K(+131.5%) | $1.26M(+119.1%) |
| Dec 2016 | $57.45M(+1385.3%) | - | - |
| Dec 2016 | - | $343.60K(+629.5%) | $576.10K(-30.2%) |
| Sep 2016 | - | $47.10K(-38.2%) | $825.50K(-54.1%) |
| Jun 2016 | - | $76.20K(-30.2%) | $1.80M(-35.6%) |
| Mar 2016 | - | $109.20K(-81.6%) | $2.80M(-25.4%) |
| Dec 2015 | $3.87M(+16.0%) | $593.00K(-42.0%) | $3.75M(-4.3%) |
| Sep 2015 | - | $1.02M(-4.7%) | $3.92M(-9.5%) |
| Jun 2015 | - | $1.07M(+1.0%) | $4.33M(+11.6%) |
| Mar 2015 | - | $1.06M(+39.4%) | $3.88M(+16.3%) |
| Dec 2014 | $3.33M(+88.9%) | $761.00K(-46.9%) | $3.33M(+5.7%) |
| Sep 2014 | - | $1.43M(+130.5%) | $3.15M(+37.6%) |
| Jun 2014 | - | $622.00K(+20.3%) | $2.29M(+10.6%) |
| Mar 2014 | - | $517.00K(-10.9%) | $2.07M(+17.4%) |
| Dec 2013 | $1.76M(-66.4%) | $580.00K(+1.2%) | $1.76M(-43.6%) |
| Sep 2013 | - | $573.00K(+42.5%) | $3.13M(-0.8%) |
| Jun 2013 | - | $402.00K(+91.4%) | $3.15M(-15.8%) |
| Mar 2013 | - | $210.00K(-89.2%) | $3.74M(-28.7%) |
| Dec 2012 | $5.25M(-37.3%) | $1.94M(+225.1%) | $5.25M(+1.5%) |
| Sep 2012 | - | $598.00K(-39.7%) | $5.17M(-19.5%) |
| Jun 2012 | - | $992.00K(-42.2%) | $6.43M(-21.5%) |
| Mar 2012 | - | $1.72M(-8.0%) | $8.18M(-2.2%) |
| Dec 2011 | $8.37M(-19.2%) | $1.87M(+0.8%) | $8.37M(+3.3%) |
| Sep 2011 | - | $1.85M(-32.6%) | $8.10M(-20.6%) |
| Jun 2011 | - | $2.75M(+44.4%) | $10.20M(+5.2%) |
| Mar 2011 | - | $1.90M(+19.2%) | $9.70M(-6.3%) |
| Dec 2010 | $10.36M(+2.7%) | $1.60M(-59.7%) | $10.36M(-6.0%) |
| Sep 2010 | - | $3.96M(+76.0%) | $11.02M(+4.5%) |
| Jun 2010 | - | $2.25M(-12.2%) | $10.54M(-0.0%) |
| Mar 2010 | - | $2.56M(+13.6%) | $10.54M(+4.5%) |
| Dec 2009 | $10.09M | $2.25M(-35.3%) | $10.09M(-2.3%) |
| Sep 2009 | - | $3.48M(+54.5%) | $10.32M(+10.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2009 | - | $2.25M(+6.8%) | $9.35M(-14.4%) |
| Mar 2009 | - | $2.11M(-15.3%) | $10.92M(-19.8%) |
| Dec 2008 | $13.62M(-33.0%) | $2.49M(-0.6%) | $13.62M(-19.7%) |
| Sep 2008 | - | $2.50M(-34.6%) | $16.95M(-13.2%) |
| Jun 2008 | - | $3.83M(-20.3%) | $19.54M(-6.2%) |
| Mar 2008 | - | $4.80M(-17.5%) | $20.83M(+2.5%) |
| Dec 2007 | $20.31M(+43.0%) | $5.82M(+14.4%) | $20.31M(+11.8%) |
| Sep 2007 | - | $5.09M(-0.5%) | $18.17M(+9.9%) |
| Jun 2007 | - | $5.12M(+19.4%) | $16.53M(+9.1%) |
| Mar 2007 | - | $4.29M(+16.5%) | $15.15M(+6.6%) |
| Dec 2006 | $14.21M(+30.4%) | $3.68M(+6.7%) | $14.21M(+5.2%) |
| Sep 2006 | - | $3.45M(-7.7%) | $13.51M(+8.7%) |
| Jun 2006 | - | $3.74M(+11.7%) | $12.43M(+5.7%) |
| Mar 2006 | - | $3.35M(+12.2%) | $11.76M(+7.9%) |
| Dec 2005 | $10.89M(+21.1%) | $2.98M(+26.2%) | $10.89M(+7.2%) |
| Sep 2005 | - | $2.36M(-22.8%) | $10.16M(-3.1%) |
| Jun 2005 | - | $3.06M(+23.3%) | $10.48M(+8.7%) |
| Mar 2005 | - | $2.48M(+10.4%) | $9.64M(+7.2%) |
| Dec 2004 | $9.00M(+11.7%) | $2.25M(-16.2%) | $9.00M(-0.4%) |
| Sep 2004 | - | $2.69M(+20.7%) | $9.03M(+18.9%) |
| Jun 2004 | - | $2.22M(+21.1%) | $7.60M(-3.5%) |
| Mar 2004 | - | $1.84M(-19.6%) | $7.87M(-2.3%) |
| Dec 2003 | $8.06M(-21.0%) | $2.29M(+82.5%) | $8.06M(-17.6%) |
| Sep 2003 | - | $1.25M(-49.9%) | $9.78M(-8.9%) |
| Jun 2003 | - | $2.50M(+23.5%) | $10.73M(+2.5%) |
| Mar 2003 | - | $2.02M(-49.6%) | $10.47M(+2.6%) |
| Dec 2002 | $10.20M(+136.0%) | $4.01M(+81.8%) | $10.20M(+33.3%) |
| Sep 2002 | - | $2.21M(-1.3%) | $7.65M(+20.5%) |
| Jun 2002 | - | $2.23M(+27.3%) | $6.35M(+24.8%) |
| Mar 2002 | - | $1.76M(+20.5%) | $5.09M(+17.8%) |
| Dec 2001 | $4.32M(-36.3%) | $1.46M(+61.5%) | $4.32M(-31.6%) |
| Sep 2001 | - | $902.00K(-7.3%) | $6.32M(-3.6%) |
| Jun 2001 | - | $973.00K(-1.6%) | $6.56M(-2.4%) |
| Mar 2001 | - | $989.00K(-71.4%) | $6.72M(-1.0%) |
| Dec 2000 | $6.79M(+65.6%) | $3.46M(+202.8%) | $6.79M(+22.7%) |
| Sep 2000 | - | $1.14M(+0.6%) | $5.54M(+10.8%) |
| Jun 2000 | - | $1.13M(+7.0%) | $4.99M(-1.3%) |
| Mar 2000 | - | $1.06M(-51.8%) | $5.06M(+5.4%) |
| Dec 1999 | $4.10M(+5.1%) | $2.20M(+266.7%) | $4.80M(+9.1%) |
| Sep 1999 | - | $600.00K(-50.0%) | $4.40M(+2.3%) |
| Jun 1999 | - | $1.20M(+50.0%) | $4.30M(-4.4%) |
| Mar 1999 | - | $800.00K(-55.6%) | $4.50M(-2.2%) |
| Dec 1998 | $3.90M(-22.0%) | $1.80M(+260.0%) | $4.60M(+15.0%) |
| Sep 1998 | - | $500.00K(-64.3%) | $4.00M(-18.4%) |
| Jun 1998 | - | $1.40M(+55.6%) | $4.90M(-2.0%) |
| Mar 1998 | - | $900.00K(-25.0%) | $5.00M(0.0%) |
| Dec 1997 | $5.00M(+257.1%) | $1.20M(-14.3%) | $5.00M(+31.6%) |
| Sep 1997 | - | $1.40M(-6.7%) | $3.80M(+18.8%) |
| Jun 1997 | - | $1.50M(+66.7%) | $3.20M(+23.1%) |
| Mar 1997 | - | $900.00K(+12.5%) | $2.60M(-7.1%) |
| Dec 1996 | $1.40M(-46.2%) | - | - |
| Sep 1996 | - | $800.00K(-11.1%) | $2.80M(+7.7%) |
| Jun 1996 | $2.60M(+23.8%) | $900.00K(+50.0%) | $2.60M(+13.0%) |
| Mar 1996 | - | $600.00K(+20.0%) | $2.30M(+4.5%) |
| Dec 1995 | - | $500.00K(-16.7%) | $2.20M(0.0%) |
| Sep 1995 | - | $600.00K(0.0%) | $2.20M(+4.8%) |
| Jun 1995 | $2.10M(+425.0%) | $600.00K(+20.0%) | $2.10M(+31.3%) |
| Mar 1995 | - | $500.00K(0.0%) | $1.60M(+33.3%) |
| Dec 1994 | - | $500.00K(0.0%) | $1.20M(+50.0%) |
| Sep 1994 | - | $500.00K(+400.0%) | $800.00K(+33.3%) |
| Jun 1994 | $400.00K | $100.00K(0.0%) | $600.00K(+20.0%) |
| Mar 1994 | - | $100.00K(0.0%) | $500.00K(+25.0%) |
| Dec 1993 | - | $100.00K(-66.7%) | $400.00K(+33.3%) |
| Sep 1993 | - | $300.00K | $300.00K |
FAQ
- What is Moderna annual SGA?
- What is the all time high annual SGA for Moderna?
- What is Moderna annual SGA year-on-year change?
- What is Moderna quarterly SGA?
- What is the all time high quarterly SGA for Moderna?
- What is Moderna quarterly SGA year-on-year change?
- What is Moderna TTM SGA?
- What is the all time high TTM SGA for Moderna?
- What is Moderna TTM SGA year-on-year change?
What is Moderna annual SGA?
The current annual SGA of MRNA is $1.17B
What is the all time high annual SGA for Moderna?
Moderna all-time high annual SGA is $1.55B
What is Moderna annual SGA year-on-year change?
Over the past year, MRNA annual SGA has changed by -$375.00M (-24.21%)
What is Moderna quarterly SGA?
The current quarterly SGA of MRNA is $212.00M
What is the all time high quarterly SGA for Moderna?
Moderna all-time high quarterly SGA is $470.00M
What is Moderna quarterly SGA year-on-year change?
Over the past year, MRNA quarterly SGA has changed by -$62.00M (-22.63%)
What is Moderna TTM SGA?
The current TTM SGA of MRNA is $41.44B
What is the all time high TTM SGA for Moderna?
Moderna all-time high TTM SGA is $70.59B
What is Moderna TTM SGA year-on-year change?
Over the past year, MRNA TTM SGA has changed by +$39.92B (+2629.64%)